Galaxy phone and tablet owners in Spain get a free Audible subscription
sammobile.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sammobile.com Daily Mail and Mail on Sunday newspapers.
Researchers develop high-sensitivity system to detect SARS-CoV-2 in the air
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Researchers develop new system for direct detection of SARS-CoV-2 in aerosols
Researchers from the Polytechnic University of Valencia (UPV), in collaboration with specialists from the University of Valencia (UV), have come up with a new system based on a high-sensitivity mass biosensor that continuously monitors signals for the direct detection of SARS-CoV-2 in environmental aerosols. The device, in prototype phase, makes it possible to assess the quality of the air and allows an early detection of the virus in inside spaces such as homes, classrooms, restaurants, cinemas or means of transportation. This way of spreading is gaining importance, which is why preventive control strategies must take into account the spreading of the virus via aerosols for an effective mitigation of SARS-CoV-2. The system we have developed is based on a mass biosensor that uses specific antibodies that can detect the SARS-CoV-2 virus in the air, highlights ángel Maquieira, professor of the Department
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Igenomix Expands Its Presence In North America With The Acquisition Of Access Genomics Canada
December 17, 2020 GMT
- Canada carries out 33,000 IVF cycles per year
TORONTO, Dec. 17, 2020 /PRNewswire/ On December 14th, 2020 Igenomix announced the acquisition of the Toronto-based laboratory Access Genomics, owned by Persistence Capital Partners. This reinforces Igenomix position in a growing country in the field of reproductive medicine, where it can better serve the needs of its clients in the Toronto area.
Igenomix, which already had a presence in Canada through its representative office, has established itself as a leading laboratory in Toronto. This acquisition of Access Genomics laboratory will also enable the biotechnology company to increase its portfolio of clients to a total of 36 reproduction clinics and offer quality service to its clientele.